Guide

The ResMed Astral 100/150 recall and pre-owned Astral resale

ResMed is correcting Astral 100 and 150 ventilators built before October 2024. What it is, which units are affected, and what it means for buying or selling a pre-owned Astral.

Last checked September 29, 2026.

What the recall is

A supercapacitor on the main circuit board (the PCBA) can leak and damage the board; the ventilator may then enter a fail-safe state in which therapy stops and alarms sound.

ResMed's patient letter was dated June 25, 2026. The FDA issued an early alert on July 15, 2026 and classified the correction as Class I, its most serious category, on July 31, 2026. As of June 23, 2026 ResMed had reported five serious injuries and no deaths.

Is my unit affected

Astral 100 and 150 units built before October 2024, serial numbers below 22241890149; the serial is on the underside label and the device information screen. The original 2023 notice covered units built from 2013 to 2019; the July 2026 action widened it.

Patients should not stop using the ventilator unless a clinician says so; providers keep backup ventilation available.

What ResMed is doing

Phased inspection and main-board replacement at authorized service centers, prioritized by patient risk. No single permanent fix has been announced, so a unit's status is whether its recall inspection or board replacement has been completed and documented.

Buying a pre-owned Astral now

Every Astral serial is checked against the affected list. Ameristart lists an affected unit as Patient Ready only when ResMed's recall inspection (supercapacitor tested and passed) or main-board replacement has been completed by an authorized service center and documented; that documentation ships with the unit. Otherwise it is sold as-is, labeled as-is.

Each Astral listing carries a Recall row; the paperwork is available before purchase. Ameristart is not a manufacturer service center: verify the serial with ResMed before placing any unit in service.

Selling an Astral you own

An Astral 150 with ResMed's recall inspection or main-board replacement completed and documented sells for about $4,000 – $4,500 patient ready; an affected unit without that documentation sells as-is, for a fraction of that. On consignment the open correction is part of the service cost on the Offer Sheet.

Consignors keep title until the sale and receive 70% of the net margin. How consignment works →